Dwi Oktari Erfanti
Research Subjects
Dwi Oktari Erfanti has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ahmedz Widiasta
Nephrology Division, Child Health Department, Faculty of Medicine, Universitas Padjadjaran, Hasan Sadikin General Hospital, Bandung, Indonesia, Indonesia
2 shared publications - Aris Primadi
Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung 40161, Indonesia
2 shared publications - Fiva Aprilia Kadi
Department of Child Health, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
2 shared publications - Johanes Edy Siswanto
Neonatology Division, Child Health Department, Harapan Kita National Women and Children Health Centre, Faculty of Medicine, Pelita Harapan University, Jakarta, Indonesia, Indonesia
2 shared publications - Tetty Yuniati
Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Dr. Hasan Sadikin General Hospital, Bandung 40161, Indonesia
2 shared publications
Latest Publications
- Open Access
- 25 February 2026
- Published by MDPI AG in Kidney and Dialysis
- Vol. 6 (1) , 14
Neutrophil Gelatinase-Associated Lipocalin as a Useful Modality in Early Acute Kidney Injury Detection Amongst Low-Birth-Weight Neonates
Background: Chronic kidney disease (CKD) and hypertension in adolescence and young adulthood are predisposing factors for cardiovascular and neurological diseases later in life. Serum creatinine levels have been routinely used as a daily practice modality for detecting acute kidney injury (AKI) in patients of all ages, but unfortunately have some limitations, such as their delayed increase during AKI events. An earlier biomarker is needed to detect AKI, notably in the neonatal period. In the present study, we aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL) could be used as a modality in detecting AKI, not only in children and adults, but also in neonates. Methods: We conducted a prospective-cohort study on preterm neonates with a gestational age of 28–34 weeks at Hasan Sadikin General Hospital, Bandung, and performed serum NGAL and creatinine measurements. Spearman’s rank correlation was used to determine the association between serum NGAL levels and AKI during the first 48 h in these neonates. Serum NGAL was measured using the Elabscience® Human NGAL ELISA kit; NGAL positivity was defined as serum NGAL > 150 ng/mL for exploratory classification. Results: Serum NGAL measurement showed a better positivity rate in detecting early AKI in neonates than creatinine (KDIGO and nRIFLE), with values of 81.8, 24.7, and 10.4, respectively. Conclusions: NGAL can be used as a modality for detecting AKI earlier in neonates.
- 25 February 2026
- Published by MDPI AG in Kidney and Dialysis
- Vol. 6 (1) , 14
Open AccessNeutrophil Gelatinase-Associated Lipocalin as a Useful Modality in Early Acute Kidney Injury Detection Amongst Low-Birth-Weight Neonates
Background: Chronic kidney disease (CKD) and hypertension in adolescence and young adulthood are predisposing factors for cardiovascular and neurological diseases later in life. Serum creatinine levels have been routinely used as a daily practice modality for detecting acute kidney injury (AKI) in patients of all ages, but unfortunately have some limitations, such as their delayed increase during AKI events. An earlier biomarker is needed to detect AKI, notably in the neonatal period. In the present study, we aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL) could be used as a modality in detecting AKI, not only in children and adults, but also in neonates. Methods: We conducted a prospective-cohort study on preterm neonates with a gestational age of 28–34 weeks at Hasan Sadikin General Hospital, Bandung, and performed serum NGAL and creatinine measurements. Spearman’s rank correlation was used to determine the association between serum NGAL levels and AKI during the first 48 h in these neonates. Serum NGAL was measured using the Elabscience® Human NGAL ELISA kit; NGAL positivity was defined as serum NGAL > 150 ng/mL for exploratory classification. Results: Serum NGAL measurement showed a better positivity rate in detecting early AKI in neonates than creatinine (KDIGO and nRIFLE), with values of 81.8, 24.7, and 10.4, respectively. Conclusions: NGAL can be used as a modality for detecting AKI earlier in neonates.
- Open Access
- 14 January 2026
- Published by MDPI AG in Preprints.org
Neutrophil Gelatinase Associated Lipocalin as a Useful Modality in Early Detection of Acute Kidney Injury Amongst Low Birth Weight Neonate
Background Chronic kidney disease (CKD) and hypertension in adolescence and young adulthood are predisposing factors for cardiovascular and neurological diseases later in life. Serum creatinine has been routinely used as a daily practice modality for detecting acute kidney injury (AKI) in patients of all ages. Unfortunately, serum creatinine levels have some limitations, such as the delayed increase among AKI events. An earlier biomarker is needed to detect AKI, notably in the neonatal period. The present study aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL) could be used as a modality in detecting AKI, not only in children and adults, but also in neonates. Methods A prospective-cohort study conducted at Hasan Sadikin General Hospital, Bandung, on preterm neonates with a gestational age of 28 – 34 weeks, and performed serum NGAL and creatinine measurements. Spearman’s rank correlation was used to determine the association between serum NGAL levels and AKI during the first 48 h in these neonates. Results Serum NGAL measurement showed better positivity rate than creatinine (KDIGO and nRIFLE) in detecting early AKI in neonates, with values of 81.8, 24.7, and 10.4, respectively. Conclusion NGAL can be used as a modality in detecting AKI in neonates earlier.
- 14 January 2026
- Published by MDPI AG in Preprints.org
Open AccessNeutrophil Gelatinase Associated Lipocalin as a Useful Modality in Early Detection of Acute Kidney Injury Amongst Low Birth Weight Neonate
Background Chronic kidney disease (CKD) and hypertension in adolescence and young adulthood are predisposing factors for cardiovascular and neurological diseases later in life. Serum creatinine has been routinely used as a daily practice modality for detecting acute kidney injury (AKI) in patients of all ages. Unfortunately, serum creatinine levels have some limitations, such as the delayed increase among AKI events. An earlier biomarker is needed to detect AKI, notably in the neonatal period. The present study aimed to determine whether neutrophil gelatinase-associated lipocalin (NGAL) could be used as a modality in detecting AKI, not only in children and adults, but also in neonates. Methods A prospective-cohort study conducted at Hasan Sadikin General Hospital, Bandung, on preterm neonates with a gestational age of 28 – 34 weeks, and performed serum NGAL and creatinine measurements. Spearman’s rank correlation was used to determine the association between serum NGAL levels and AKI during the first 48 h in these neonates. Results Serum NGAL measurement showed better positivity rate than creatinine (KDIGO and nRIFLE) in detecting early AKI in neonates, with values of 81.8, 24.7, and 10.4, respectively. Conclusion NGAL can be used as a modality in detecting AKI in neonates earlier.